Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiation Injuries | 6 | 2019 | 1189 | 1.470 |
Why?
|
| Radiosurgery | 10 | 2023 | 1342 | 1.130 |
Why?
|
| Cranial Irradiation | 4 | 2020 | 390 | 0.920 |
Why?
|
| Meningeal Neoplasms | 3 | 2024 | 1248 | 0.650 |
Why?
|
| Brain Neoplasms | 11 | 2023 | 9031 | 0.650 |
Why?
|
| Cholecystitis | 1 | 2017 | 180 | 0.530 |
Why?
|
| Gallbladder | 1 | 2017 | 308 | 0.500 |
Why?
|
| Glioblastoma | 5 | 2023 | 3482 | 0.440 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 3 | 2023 | 1661 | 0.390 |
Why?
|
| Liver Neoplasms | 3 | 2017 | 4317 | 0.390 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 916 | 0.360 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 21019 | 0.350 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 552 | 0.320 |
Why?
|
| Bile Duct Neoplasms | 1 | 2014 | 605 | 0.310 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 926 | 0.300 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 1085 | 0.300 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1667 | 0.290 |
Why?
|
| Radiotherapy Dosage | 4 | 2023 | 2898 | 0.210 |
Why?
|
| Dacarbazine | 2 | 2015 | 559 | 0.200 |
Why?
|
| Heart | 1 | 2015 | 4404 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.200 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 2297 | 0.190 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2015 | 617 | 0.190 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 8002 | 0.190 |
Why?
|
| Neurilemmoma | 1 | 2024 | 526 | 0.160 |
Why?
|
| Lung | 2 | 2015 | 10002 | 0.150 |
Why?
|
| Tumor Burden | 3 | 2018 | 1893 | 0.130 |
Why?
|
| Cholelithiasis | 1 | 2017 | 407 | 0.120 |
Why?
|
| Patient Care | 1 | 2021 | 622 | 0.120 |
Why?
|
| Meningioma | 1 | 2024 | 1218 | 0.120 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2017 | 882 | 0.120 |
Why?
|
| Inhalation | 1 | 2015 | 143 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2017 | 590 | 0.120 |
Why?
|
| Prognosis | 5 | 2023 | 29629 | 0.110 |
Why?
|
| Bayes Theorem | 2 | 2023 | 2330 | 0.110 |
Why?
|
| Cysts | 1 | 2019 | 681 | 0.110 |
Why?
|
| Organs at Risk | 1 | 2015 | 359 | 0.110 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2014 | 296 | 0.110 |
Why?
|
| Rectal Neoplasms | 1 | 2021 | 1157 | 0.100 |
Why?
|
| Retrospective Studies | 10 | 2023 | 80646 | 0.090 |
Why?
|
| Humans | 27 | 2024 | 761578 | 0.090 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 938 | 0.090 |
Why?
|
| Female | 16 | 2023 | 392688 | 0.080 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2015 | 801 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1222 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 2072 | 0.070 |
Why?
|
| Erythroid Precursor Cells | 1 | 2008 | 211 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8528 | 0.070 |
Why?
|
| Aged | 10 | 2019 | 169308 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 1324 | 0.060 |
Why?
|
| Middle Aged | 11 | 2019 | 220917 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 39107 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5368 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 774 | 0.060 |
Why?
|
| Incidence | 1 | 2023 | 21355 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2008 | 683 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2020 | 54423 | 0.060 |
Why?
|
| Adenoma | 1 | 2014 | 2163 | 0.060 |
Why?
|
| Thalidomide | 1 | 2008 | 885 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 12463 | 0.050 |
Why?
|
| Progestins | 1 | 2024 | 301 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6992 | 0.050 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 58983 | 0.050 |
Why?
|
| Genomics | 1 | 2017 | 5821 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6180 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2019 | 64684 | 0.050 |
Why?
|
| Glioma | 1 | 2016 | 3455 | 0.050 |
Why?
|
| Liver | 1 | 2017 | 7527 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8656 | 0.050 |
Why?
|
| Male | 12 | 2021 | 360841 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6346 | 0.040 |
Why?
|
| Random Allocation | 1 | 2023 | 2395 | 0.040 |
Why?
|
| Steroids | 1 | 2024 | 929 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11122 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6484 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2008 | 1394 | 0.040 |
Why?
|
| Standard of Care | 1 | 2021 | 551 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 709 | 0.030 |
Why?
|
| Algorithms | 3 | 2022 | 14032 | 0.030 |
Why?
|
| Brain | 2 | 2022 | 27121 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 30054 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2010 | 11530 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 23447 | 0.030 |
Why?
|
| Infection Control | 1 | 2021 | 982 | 0.030 |
Why?
|
| Necrosis | 1 | 2018 | 1611 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 36426 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 2526 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13382 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 359 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 3769 | 0.030 |
Why?
|
| Adult | 6 | 2019 | 221200 | 0.030 |
Why?
|
| Hypopituitarism | 1 | 2014 | 250 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 1980 | 1333 | 0.030 |
Why?
|
| Genotype | 2 | 2017 | 12990 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1638 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2018 | 1264 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20569 | 0.020 |
Why?
|
| Acromegaly | 1 | 2014 | 310 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2644 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 548 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 74212 | 0.020 |
Why?
|
| Stents | 1 | 2023 | 3179 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2014 | 834 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 72 | 0.020 |
Why?
|
| Anesthesiology | 1 | 1980 | 1120 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 133 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2017 | 1958 | 0.020 |
Why?
|
| Risk | 1 | 2021 | 9610 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2023 | 5079 | 0.020 |
Why?
|
| Cause of Death | 1 | 2019 | 3683 | 0.020 |
Why?
|
| Africa | 1 | 2010 | 709 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3766 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1913 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6766 | 0.020 |
Why?
|
| Radiology | 1 | 2021 | 2113 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2008 | 386 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1699 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 629 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11120 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10212 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 1386 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12725 | 0.010 |
Why?
|
| RNA Interference | 1 | 2010 | 2832 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2601 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12059 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9281 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13510 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23996 | 0.010 |
Why?
|
| Suction | 1 | 1980 | 266 | 0.010 |
Why?
|
| Young Adult | 2 | 2016 | 59254 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18398 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81539 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2008 | 3397 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13642 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18966 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 9420 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15266 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 168475 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 36193 | 0.000 |
Why?
|
| Child | 1 | 2014 | 80157 | 0.000 |
Why?
|
| Adolescent | 1 | 2014 | 88323 | 0.000 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(107)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_